Outlook Therapeutics, Inc. announced the appointment of Jedd Comiskey as Senior VP ? Head of Europe. Mr. Comiskey has a successful track record in the planning, organization and execution of product launches.

Over the course of his career, he has demonstrated innovative, solution-focused results, navigating the highly complex European pharmaceutical landscape. Prior to joining the company, Jedd served as the Senior Brand Director; Ophthalmology at Apellis Switzerland GmbH. As part of his role, Jedd was the commercial lead for the launch of SYFOVRE® (pegcetacoplan), defining regional brand strategy, formulating key market commercialization plans, engaging stakeholders, and supporting affiliates with launch preparations.

In addition to his regional role, Jedd was accountable for detailed mapping of the ophthalmology landscape, preparatory stakeholder engagement and formulation of comprehensive commercialization strategy, and infrastructure plans at Apellis. Prior to that, Jedd served as the Franchise Head GI Rare at Takeda Pharmaceuticals International AG where he was responsible for directing the company?s commercial launch across Europe and Canada for two treatments indicated for rare gastrointestinal disorders. He also served as the Director of Market Access and Marketing at Takeda Products Ireland Ltd. Additional career appointments include Head of Market Access at Bayer Ltd, Market Access Manager at Takeda Products Ireland Ltd, Product Manager: ADHD at Shire Pharmaceuticals Ireland Ltd, and Cardiovascular Product Manager at Servier Laboratories Ireland Ltd. Mr. Comiskey holds a Bachelor of Science in Chemistry from the University College Dublin and a PhD in Chemistry from the Royal College of Surgeons in Ireland.